Melvin Chin

Senior Lecturer

Melvin Chin is a clinical academic medical oncologist – he cares for patients with lung, melanoma, gastrointestinal and other cancers and he teaches UNSW medical students in the Oncology and Palliative Care term. He was the Head of Department-Medical Oncology at the Prince of Wales Hospital from 2015-2018 overseeing the move of clinical services into the Nelune Comprehensive Cancer Centre and the seemless collaboration with the Scientia Clinical Research. He is a member of the South Eastern Sydney Local Health District Human Research Ethics Committee. He has contributed to numerous clinical trials and health services research studies and continues to nurture new research collaborations. 

Conference Abstracts
add
Chah KT; Chin M; Siu HW; Brell N, 2019, 'A retrospective audit of male prisoners referred to Cancer Services at Prince of Wales Hospital', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide Convention Centre, Vol. 15, pp. 134 - 134, presented at Clinical Oncology Society of Australia, Adelaide Convention Centre, 12 November 2019 - 14 November 2019, http://dx.doi.org/10.1111/ajco.13263
2019
Foong M; Botes L; Shum M; Schipp D; Porwal M; Barat S; Chin M, 2019, 'Do we have a black cat in a dark room? Looking for patient data in cancer research', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide Convention Centre, Vol. 15, pp. 212 - 213, presented at Clinical Oncology Society of Australia Annual Scientific Meeting, Adelaide Convention Centre, 12 November 2019 - 14 November 2019, http://dx.doi.org/10.1111/ajco.13263
2019
Vaughan BK; Rossleigh M; Parasyn A; Chin M, 2018, 'The Ability of BRAF Therapy to Convert an Iodine Negative to Iodine Positive Thyroid Cancer Patient', in World Journal of Nuclear Medicine, Medknow Publications, Melbourne, Vol. 17, pp. 49 - 342, presented at 12th Congress of the World Federation of Nuclear Medicine and Biology, Melbourne, 20 April 2018 - 24 April 2018, http://www.wjnm.org/text.asp?2018/17/5/49/241904
2018
Taylor N; Williams R; Debono D; Chin M; Long J; Salisbury E; Butler J; Potter M; O'Neill S; Braithwaite J, (ed.), 2015, 'ACHIEVING HEALTHCARE PROFESSIONAL BEHAVIOUR CHANGE FOR DETECTION AND MANAGEMENT OF LYNCH SYNDROME', in ACHIEVING HEALTHCARE PROFESSIONAL BEHAVIOUR CHANGE FOR DETECTION AND MANAGEMENT OF LYNCH SYNDROME, Wiley Online Library, Hobart, Tasmania, Australia, Vol. 11, pp. 102 - 103, presented at Clinical Oncology Society of Australia 42nd Annual Meeting, Hobart, Tasmania, Australia, 17 November 2015 - 19 November 2015, http://dx.doi.org/10.1111/ajco.12432_2
2015
Liang R; Meiser B; Smith S; Kasparian N; Lewis C; Chin M; Long G; Ward R; Menzies A; Gumniski A; Harris J; Kaur R, 2015, 'Oncology patients’ attitudes toward, and experiences with, somatic mutation tumour testing', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, Tasmania, Australia, Vol. 11, pp. 144 - 144, presented at Clinical Oncology Society of Australia 42nd Annual Meeting, Tasmania, Australia, 17 December 2015 - 19 November 2015, http://dx.doi.org/10.1111/ajco.12432_2
2015
Journal articles
add
Lamprell K; Chin M; Braithwaite J, 2019, '“Can I still get a tattoo?” Patients’ experiences across the clinical trajectory for metastatic melanoma: a dynamic narrative model of patient journey', Patient Experience Journal, vol. 6, pp. 87 - 93, http://dx.doi.org/10.35680/2372-0247.1301
2019
Lamprell K; Chin M; Braithwaite J, 2018, 'The plot thickens: Archetypal narrative structure in the melanoma patient journey', Cogent Medicine, vol. 5, pp. 1 - 11, http://dx.doi.org/10.1080/2331205x.2018.1484053
2018
Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Butler J; Rawson R; Phan-Thien KC; Thompson SR; Braithwaite J; Chin M; Taylor N, 2018, 'Using behaviour change and implementation science to address low referral rates in oncology 11 Medical and Health Sciences 1117 Public Health and Health Services', BMC Health Services Research, vol. 18, pp. 904, http://dx.doi.org/10.1186/s12913-018-3653-1
2018
Liang R; Meiser B; Smith S; Kasparian NA; Lewis CR; Chin M; Long GV; Ward R; Menzies AM; Harris-Wai JN; Kaur R, 2017, 'Advanced cancer patients’ attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study', European Journal of Cancer Care, vol. 26, http://dx.doi.org/10.1111/ecc.12600
2017
Sandler CX; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; segelov E; Boyle FM; Chin MT; webber K; Barry BK; Lloyd AR, 2017, 'Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue.', Journal of Pain and Symptom Management, vol. 54, pp. 74 - 84, http://dx.doi.org/10.1016/j.jpainsymman.2017.03.015
2017
Pianta TJ; Pickering JW; Succar L; Chin M; Davidson T; Buckley NA; Mohamed F; Endre ZH, 2017, 'Dexamethasone Modifies Cystatin C-Based Diagnosis of Acute Kidney Injury During Cisplatin-Based Chemotherapy', Kidney and Blood Pressure Research, vol. 42, pp. 62 - 75, http://dx.doi.org/10.1159/000469715
2017
Schütze H; Chin M; Weller D; Harris MF, 2017, 'Patient, general practitioner and oncologist views regarding long-term cancer shared care.', Fam Pract, vol. 35, pp. 323 - 329, http://dx.doi.org/10.1093/fampra/cmx105
2017
He EYJ; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: An Australian population-based multicenter study', Oncologist, vol. 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530
2016
Lemech CR; Williams R; Thompson SR; McCaughan B; Chin M, 2016, 'Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: A case report', BMC Research Notes, vol. 9, http://dx.doi.org/10.1186/s13104-016-2189-x
2016
Bloem LT; De Abreu Lourenço R; Chin M; Ly B; Haas M, 2016, 'Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer', Oncology and Therapy, vol. 4, pp. 103 - 116, http://dx.doi.org/10.1007/s40487-016-0020-4
2016
Taylor N; Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Braithwaite J; Chin M, 2016, 'Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: A study protocol', BMC Health Services Research, vol. 16, http://dx.doi.org/10.1186/s12913-016-1331-8
2016
Chin M; Ward RL, 2014, 'Targeting treatment for colorectal cancer: The EGFR antibody story', Cancer Forum, vol. 38, pp. 39 - 43
2014
Mak G; Chin M; Nahar N; De Souza P, 2014, 'Cutaneous metastasis of prostate carcinoma treated with radiotherapy: A case presentation', BMC Research Notes, vol. 7, http://dx.doi.org/10.1186/1756-0500-7-505
2014
Mak G; Arkenau HT; Chin M, 2014, 'Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment', Melanoma Research, vol. 24, pp. 408 - 412, http://dx.doi.org/10.1097/CMR.0000000000000085
2014
Falchook GS; Long GV; Kurzrock R; Kim KB; Arkenau HT; Brown MP; Hamid O; Infante JR; Millward M; Pavlick A; Chin MT; O'Day SJ; Blackman SC; Martin C; Lebowitz P; Ma B; Ouellet D; Kefford RF, 2014, 'Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)', Clinical Cancer Research, vol. 20, pp. 4449 - 4458, http://dx.doi.org/10.1158/1078-0432.CCR-14-0887
2014
Pianta T; Chin M; Peake P; Buckley N; Pickering J; Endre Z, 2013, 'PLASMA CYSTATIN C IS ELEVATED IN THE ABSENCE OF ACUTE KIDNEY INJURY FOLLOWING CISPLATIN WITH CONTEMPORARY ANTIEMETICS', NEPHROLOGY, vol. 18, pp. 41 - 41, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323453000103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Mak G; Ward R; Shehabi Y; Venkateswaran R; Chin M, 2013, 'Use of neostigmine in capecitabine-induced paralytic ileus', Tumori, vol. 99, http://dx.doi.org/10.1700/1377.15320
2013
Pourgholami MH; Szwajcer ; Chin MTM; Liauw WS; Szwajcer ; Galettis P; Morris DL; Links MJ, 2010, 'Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, vol. 65, pp. 597 - 605, http://dx.doi.org/10.107/s00280-009-1157-8
2010
Pearson S; Chin M; Faedo M; Ward RL, 2010, 'Rationale for treatment durations of targeted cancer agents', Lancet Oncology, vol. 11, pp. 1113 - 1115, http://dx.doi.org/10.1016/S1470-2045(10
2010
Pourgholami MH; Szwajcer M; Chin M; Liauw W; Seef J; Galettis P; Morris DL; Links M, 2010, 'Phase i clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, vol. 65, pp. 597 - 605, http://dx.doi.org/10.1007/s00280-009-1157-8
2010
Grimison PS; T Chin M; Harrison ML; Goldstein D, 2006, 'Primary pancreatic lymphoma - pancreatic tumours that are potentially curable without resection, a retrospective review of four cases', BMC Cancer, vol. 6, http://dx.doi.org/10.1186/1471-2407-6-117
2006
Wierzbicki AS; Reynolds TM; Crook MA; Tatler J; Peters BS; McBride M; Chin MTM; Lee SM; Kelly B, 1998, 'Lipid lowering therapy in patients with HIV infection (multiple letters) [3]', Lancet, vol. 352, pp. 1782 - 1783
1998
Conference Presentations
add
Chin M; Harris M; Taggart J; Liauw W, 2019, 'Sharing the care of patients with cancer between specialists and general practitioners', presented at Australasian College of Health Service Management, Gold Coast Convention Centre, 09 October 2019 - 11 October 2019
2019
Harris M; Schutze H; Chin MT; Weller D; Suchy S, 2016, 'Patient, specialist and GP perspectives on sharing cancer care: It takes at least three to tango', presented at 2016 Primary Health Care Research Conference, National Convention Centre, Canberra, 08 June 2016 - 09 June 2016, http://www.phcris.org.au/roar/profiles/featured-activity.php?id=18599#all
2016
Debono D; Taylor N; Long J; Braithwaite J; Chin MT; Williams R; Salisbury E; O'Neill S; Dunlop T; Phan-Tien K; Eykman E, 2015, 'Referral as imagined versus referral as done: mapping the referral process for genetic counselling for Lynch syndrome patients', presented at 2015 Innovations in Cancer Treatment and Care Conference, Aerial UTS Function Centre, Sydney, 15 October 2015 - 15 October 2015, https://www.cancerinstitute.org.au/about-us/events/innovations-in-cancer-treatment-and-care/Past-conferences/Abstracts/referral-as-imagined-versus-referral-as-done-mapp
2015
Harris M; Weller D; Ward R; Chin M; Meiser B; Crowley M, 2014, 'ATTITUDES TO CANCER FOLLOW-UP CARE IN GENERAL PRACTICE', Vol. 10, pp. 65 - 65, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Pianta TJ; Chin M; Peake PW; Buckely NA; Pickering JW; Endre ZH, 2013, 'PLASMA CYSTATIN C IS ELEVATED IN THE ABSENCE OF ACUTE KIDNEY INJURY FOLLOWING CISPLATIN WITH CONTEMPORARY ANTIEMETICS', presented at 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology,, Brisbane, 09 September 2013 - 11 September 2013
2013
Reports
add
Taggart J; Harris MF; Chin M, 2018, Cancer Shared eCare Plan Information Requirements and Care Plan Templates Jan 2018
2018
Conference Posters
add
Williams R; Long J; Debono D; Chin MT; Taylor N, 2017, 'WORKING WITH CLINICIANS TO IDENTIFY BARRIERS TO FAMILY CANCER CLINIC REFERRALS FOR PATIENTS AT HIGH RISK OF LYNCH SYNDROME', Florence, presented at InSIGHT 7th Biennial Meeting, Florence, 05 July 2017 - 08 July 2017, http://www.2017insight.com/
2017
Feeney K; Chin M; Ng S; Matos M; Mak G; McKendrick J, 2014, 'AFLIBERCEPT IN METASTATIC COLORECTAL CANCER (MCRC): DATA FROM CLINICAL TRIALS, LESSONS FROM CLINICAL PRACTICE', Melbourne, Vol. 10 Supplement S8, pp. 192 - 192, presented at COSA, Melbourne, 21 October 2014 - 24 October 2014, http://dx.doi.org/10.1111/ajco.12305
2014
Pianta TJ; Peake P; Buckley NA; Pickering JW; Chin M; Endre ZH, (ed.), 2013, 'Plasma Cystatin C Should Not Be Used to Diagnose AKI after Cisplatin Therapy', Atlanta, GA, USA, Vol. 24, pp. 373A - 373A, presented at American Society of Nephrology Kidney Week 2013, Atlanta, GA, USA, 05 November 2013 - 10 November 2013
2013
Conference Papers
add
Chin TTC; Botes LLB; Chin MMC, 2017, 'Compassionate Supply of Oncology Drugs Within the South Eastern Sydney Local Health District (SESLHD) in 2011-2015', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 188 - 188, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500311&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2017
Segelov E, 2015, 'TOPS - a randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, presented at 2015 ASCO Annual Meeting, Chicago, 29 May 2015 - 02 June 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036902066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2015
Schutze H; Chin M; Weller D; Suchy S; Harris M, 2015, 'Attitudes to cancer follow-up care in general practice - preliminary findings', in Attitudes to cancer follow-up care in general practice - preliminary findings, Health Science Alliance - Fourth Annual Scientific Symposium, Royal Womens Hospital, Randwick, Australia, presented at Health Science Alliance - Fourth Annual Scientific Symposium, Royal Womens Hospital, Randwick, Australia, 19 November 2015 - 19 November 2015, https://thehealthsciencealliance.org/sites/default/files/hsa/PPT/11_PM_Session3_3_Schutze_Breast%20and%20colorectal%20cancer.pdf
2015
Sandler C; Webber K; Friedlander M; Lewis C; Chin M; Venkateswaran R; Segelov E; Bastick P; Lynch J; Thomas D; Liauw W; Boyle F; Goldstein D; Lloyd A, 2013, 'BARRIERS TO RECRUITMENT FOR A POST-CANCER FATIGUE INTERVENTION STUDY - THE TOPS TRIAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Lemech C; Fontela A; Arkenau H; Chin M; Li S; Liauw WS; Thomas D; De Souza P, 2012, 'Phase I study of everolimus in combination with fluvastatin and zoledronic acid in patients with solid tumours', in Journal of clinical oncology - official journal of the American Society of Clinical Oncology, American Society of Clinical Oncology, New York, pp. e13585 - e13585, presented at ASCO Annual Meeting, Chicago, USA, 01 June 2012 - 05 June 2012, http://meeting.ascopubs.org/gca?gca=ascomtg%3B30%2F15_suppl%2Fe13585&allch=&submit=Go#abstr-1
2012
Herder GJ; Agulnik J; Amadori D; Chin M; Chouaid C; Ek L; Lester J; Ziske C; Eriksson J; Finnern H; Vansteenkiste J, 2011, 'Describing treatment, treatment outcomes, resource use and quality of life of advanced NSCLC patients – the Lung Cancer Economics and Outcomes Research (LUCEOR) studies.', in Journal of Thoracic Oncology, Lippincott Williams & Wilkins, USA, pp. 1404 - 1405, presented at Proceedings of the 14th World Conference on Lung Cancer, Amsterdam, http://dx.doi.org/10.1097/01.JTO.0000399290.73317.eb
2011
Pearson S; Chin M; Ward RL, 2009, 'The Financially Tolerable Dose: A New Concept in Cancer Trial Design', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S173 - S174, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269009900396&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2009
Other
add
Pal A (ed.), 2016, Between Cure and Palliation, onthewards, https://onthewards.org/between-cure-and-palliation/
2016